inking protein profiles to disease progression and clinical expression in Parkinson*s disease
- Conditions
- Parkinson's diseasemovement disorders10028037
- Registration Number
- NL-OMON33857
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 282
PATIENTS
(1) Patients of the outpatient clinic for movement disorders with a suspected parkinsonian syndrome, based upon the presence of at least one of the following parkinsonian symptoms: hypokinesia, bradykinesia, rigidity, tremor or postural instability.
(2) Patients already under treatment at the outpatient clinic for movement disorders and diagnosed with PD or one of the following other parkinsonian syndromes: MSA, PSP, vascular parkinsonism.
(3) Being able to understand the aim of the study and the study procedure and give written informed consent;HEALTHY CONTROLS
Being able to understand the aim of the study and the study procedure and give written informed consent
PATIENTS
(1) A history of neurological disorders other than a parkinsonian syndrome, that affect the central nervous system or are known to influence CSF proteins
(2) Use of anticoagulants or indications for coagulation disorders
(3) Infected skin over the needle entry side for lumbar puncture
(4) Signs of raised intracranial pressure
(5) Unwillingness to be informed of unexpected medical findings;HEALTHY CONTROLS
(1) A history of neurological disorders that affect the central nervous system or are known to influence CSF proteins
(2) Abnormal findings at general neurological examination
(3) Use of anticoagulants or indications for coagulation disorders
(4) Infected skin over the needle entry side for lumbar puncture
(5) Signs of raised intracranial pressure
(6) Unwillingness to be informed of unexpected medical findings
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method